Thrombocytopenia causes: Difference between revisions
Ochuko Ajari (talk | contribs) |
No edit summary |
||
(189 intermediate revisions by 13 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thrombocytopenia}} | {{Thrombocytopenia}} | ||
{{CMG}}; {{AE}} {{Ochuko}}, [https://www.wikidoc.org/index.php/User:Farbod_Zahedi_Tajrishi <nowiki>Farbod Zahedi Tajrishi, M.D. [2]</nowiki>] | |||
==Overview== | ==Overview== | ||
There are two broad mechanisms for the causes of thrombocytopenia: Reduced platelet production and increased platelet destruction. Thrombocytopenia is seen in a variety of infectious and genetic disorders as well as a side effect of a large list of medications. | There are two broad mechanisms for the causes of thrombocytopenia: Reduced platelet production and increased platelet destruction. Thrombocytopenia is seen in a variety of infectious and genetic disorders as well as a side effect of a large list of medications. | ||
Line 9: | Line 8: | ||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. | |||
*[[Disseminated intravascular coagulation]] | |||
* [[HELLP syndrome]] | |||
===Common Causes=== | ===Common Causes=== | ||
* [[Abruptio placentae]]<ref name="pmid23233580">{{cite journal| author=Stasi R| title=How to approach thrombocytopenia. | journal=Hematology Am Soc Hematol Educ Program | year= 2012 | volume= 2012 | issue= | pages= 191-7 | pmid=23233580 | doi=10.1182/asheducation-2012.1.191 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23233580 }} </ref> | |||
* [[Bone marrow suppression]] ([[chemotherapy]], [[irradiation]]) | |||
* [[coronary artery bypass surgery|Cardica bypass]]<ref name="pmid23233580">{{cite journal| author=Stasi R| title=How to approach thrombocytopenia. | journal=Hematology Am Soc Hematol Educ Program | year= 2012 | volume= 2012 | issue= | pages= 191-7 | pmid=23233580 | doi=10.1182/asheducation-2012.1.191 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23233580 }} </ref> | |||
* [[Alcoholism|Chronic alcohol use]] | |||
* [[Chronic liver disease]]<ref name="pmid24267279">{{cite journal| author=Greenberg EM, Kaled ES| title=Thrombocytopenia. | journal=Crit Care Nurs Clin North Am | year= 2013 | volume= 25 | issue= 4 | pages= 427-34, v | pmid=24267279 | doi=10.1016/j.ccell.2013.08.003 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24267279 }} </ref> | |||
* [[Common variable immunodeficiency]]<ref name="pmid23233580">{{cite journal| author=Stasi R| title=How to approach thrombocytopenia. | journal=Hematology Am Soc Hematol Educ Program | year= 2012 | volume= 2012 | issue= | pages= 191-7 | pmid=23233580 | doi=10.1182/asheducation-2012.1.191 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23233580 }} </ref> | |||
* [[Congenital|Congenital thrombocytopenia]] | |||
* [[Connective tissue disorders]] (eg [[SLE]], [[RA]], [[antiphospholipid syndrome]])<ref name="pmid23233580">{{cite journal| author=Stasi R| title=How to approach thrombocytopenia. | journal=Hematology Am Soc Hematol Educ Program | year= 2012 | volume= 2012 | issue= | pages= 191-7 | pmid=23233580 | doi=10.1182/asheducation-2012.1.191 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23233580 }} </ref> | |||
* [[Disseminated intravascular coagulation]]<ref name="pmid24267279">{{cite journal| author=Greenberg EM, Kaled ES| title=Thrombocytopenia. | journal=Crit Care Nurs Clin North Am | year= 2013 | volume= 25 | issue= 4 | pages= 427-34, v | pmid=24267279 | doi=10.1016/j.ccell.2013.08.003 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24267279 }} </ref> | |||
* [[GP IIb/IIIa inhibitor]]<ref name="pmid23233580">{{cite journal| author=Stasi R| title=How to approach thrombocytopenia. | journal=Hematology Am Soc Hematol Educ Program | year= 2012 | volume= 2012 | issue= | pages= 191-7 | pmid=23233580 | doi=10.1182/asheducation-2012.1.191 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23233580 }} </ref> | |||
* [[Hemolytic uremic syndrome]] | |||
* [[Heparin-induced thrombocytopenia]] | |||
* [[Immune thrombocytopenic purpura]]<ref name="pmid24397048">{{cite journal| author=Farid J, Gul N, Qureshi WU, Idris M| title=Clinical presentations in immune thrombocytopenic purpura. | journal=J Ayub Med Coll Abbottabad | year= 2012 | volume= 24 | issue= 2 | pages= 39-40 | pmid=24397048 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24397048 }} </ref> | |||
*[[Infections]]<ref name="pmid24267279">{{cite journal| author=Greenberg EM, Kaled ES| title=Thrombocytopenia. | journal=Crit Care Nurs Clin North Am | year= 2013 | volume= 25 | issue= 4 | pages= 427-34, v | pmid=24267279 | doi=10.1016/j.ccell.2013.08.003 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24267279 }} </ref> | |||
* [[Macrophage-activation syndrome]]<ref name="pmid23233580">{{cite journal| author=Stasi R| title=How to approach thrombocytopenia. | journal=Hematology Am Soc Hematol Educ Program | year= 2012 | volume= 2012 | issue= | pages= 191-7 | pmid=23233580 | doi=10.1182/asheducation-2012.1.191 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23233580 }} </ref> | |||
* [[Medication]]s<ref name="pmid24267279">{{cite journal| author=Greenberg EM, Kaled ES| title=Thrombocytopenia. | journal=Crit Care Nurs Clin North Am | year= 2013 | volume= 25 | issue= 4 | pages= 427-34, v | pmid=24267279 | doi=10.1016/j.ccell.2013.08.003 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24267279 }} </ref> | |||
* [[Preeclampsia]] | |||
* [[Pregnancy]]<ref name="pmid23730013">{{cite journal| author=Nisha S, Amita D, Uma S, Tripathi AK, Pushplata S| title=Prevalence and characterization of thrombocytopenia in pregnancy in Indian women. | journal=Indian J Hematol Blood Transfus | year= 2012 | volume= 28 | issue= 2 | pages= 77-81 | pmid=23730013 | doi=10.1007/s12288-011-0107-x | pmc=PMC3332269 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23730013 }} </ref> | |||
* [[Artifact|Pseudothrombocytopenia]] | |||
* [[Thrombotic thrombocytopenic purpura]]<ref name="pmid24396345">{{cite journal| author=Abdel Karim N, Haider S, Siegrist C, Ahmad N, Zarzour A, Ying J et al.| title=Approach to management of thrombotic thrombocytopenic purpura at university of cincinnati. | journal=Adv Hematol | year= 2013 | volume= 2013 | issue= | pages= 195746 | pmid=24396345 | doi=10.1155/2013/195746 | pmc=PMC3876823 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24396345 }} </ref> | |||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
{| style="width:80%; height:100px" border="1" | |||
| style="width:25%" bgcolor="LightSteelBlue" ; border="1" |'''Cardiovascular''' | |||
| style="width:75%" bgcolor="Beige" ; border="1" | [[Disseminated intravascular coagulation]], [[endocarditis]], [[pulmonary embolism]] | |||
|- | |||
| bgcolor="LightSteelBlue" | '''Chemical/Poisoning''' | |||
| bgcolor="Beige" | [[Strontium-89]],[[zinc]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Dental''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Dermatologic''' | |||
| bgcolor="Beige" | [[Cholesterol embolism]], [[Elejalde syndrome]], [[Griscelli syndrome|Griscelli syndrome type 1]], [[neuroectodermal melanolysosomal disease]], [[post-transfusion purpura]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Drug Side Effect''' | |||
| bgcolor="Beige" | [[Ado-trastuzumab emtansine]], [[albendazole]], [[alemtuzumab]], [[altretamine]], [[amiodarone]], [[Amoxicillin]], [[amphotericin B]], [[amrinone]], [[amsacrine]], [[anagrelide]], [[anazolene]], [[anti-thymocyte globulin]], [[ardeparin]], [[Asenapine maleate]], [[Aspirin]], [[azathioprine]], [[Azacitidine]], [[Aztreonam]], [[bendamustine]], [[benoxaprofen]], [[Beractant]], [[bevacizumab]], [[Boceprevir]], [[bortezomib]], [[bosutinib]], [[brentuximab vedotin]], [[cabazitaxel]], [[Cabozantinib]], [[capecitabine]], [[captopril]], [[carboplatin]], [[carfilzomib]], [[carmustine]], [[caspofungin]], [[Cefadroxil]], [[Cefepime]], [[Cefotaxime sodium]], [[Ceftazidime]], [[Cefaclor]], [[Certolizumab pegol]], [[Chlorpropamide]] , [[chlorambucil]], [[chloramphenicol]],[[clofarabine]], [[Cidofovir]], [[cilazapril]], [[cimetidine]], [[cisplatin]], [[cladribine]], [[Clemastine]], [[clofarabine]], [[Clobazam]], [[Cyclophosphamide]], [[Cytarabine]], [[cytosine arabinoside]], [[dacarbazine]], [[Dactinomycin]], [[dasatinib]], [[daunorubicin]], [[decitabine]], [[deferasirox]], [[desferrioxamine]], [[Desmopressin]], [[Dexchlorpheniramine]], [[Dexrazoxane]], [[Dextran]] [[Didanosine]], [[diflunisal]], [[docetaxel]], [[Doxorubicin Hydrochloride]], [[doxycycline]], [[Rifampin]] [[platelet|drug-induced thrombocytopenia]], [[efalizumab]], [[eflornithine]], [[Eltrombopag]], [[enoxaparin]], [[Epirubicin hydrochloride]], [[eptifibatide]], [[Eribulin]], [[Ethambutol]], [[Ethacrynic Acid]], [[etoposide]], [[everolimus]], [[febuxostat]], [[Felbamate]], [[Filgastrim]], [[flucytosine]], [[fludarabine]], [[fluorouracil]], [[fondaparinux]], [[foscarnet]], [[ganciclovir]], [[gemcitabine]], [[gemtuzumab ozogamicin]], [[glycoprotein IIb/IIIa inhibitors]], [[gold salts]], [[guanidinium]], [[Guanidine]], [[haem arginate]], [[heparin]], [[Hydrocodone bitartrate and acetaminophen]], [[hydroxycarbamide]], [[hydroxychloroquine]], [[Hydroxyurea (patient information)]], [[ibitumomab tiuxetan]], [[ibuprofen lysine]], [[ibrutinib]], [[idarubicin]], [[ifosfamide]], [[imatinib mesylate]], [[Indinavir]], [[indomethacin]], [[integrilin]], [[interferon alpha]], [[interferon alfacon-1]], [[Imipenem-Cilastatin]],[[Interferon beta- 1a]], [[Interferon gamma]], [[interleukin 10]], [[interleukin 2]], [[irinotecan hydrochloride]], [[Isoniazid]], [[isotretinoin]], [[ixabepilone]], [[Lapatinib]],[[lenalidomide]], [[Letrozole]], [[linezolid]], [[lomustine]], [[low molecular weight heparin]]s, [[Loxapine]], [[melphalan]], [[mercaptopurine]], [[Meropenem]], [[methimazole]], [[methotrexate]], [[methyldopa]], [[methyldopate]], [[methylphenidate]], [[micafungin sodium]], [[Milnacipran hydrochloride]], [[minocycline hydrochloride]], [[miltefosine]], [[mithramycin]], [[mitomycin]], [[mitoxantrone]], [[MMR vaccine]], [[montelukast]], [[nabumetone]], [[nelarabine]], [[niacin]], [[nilotinib]], [[nitisinone]], [[Nizatidine]], [[obinutuzumab]], [[Ofatumumab]], [[Omacetaxine]], [[omacetaxine mepesuccinate]], [[Olsalazine]], [[oxaliplatin]], [[Oxaprozin]], [[oxcarbazepine]], [[Oxytetracycline]], [[paclitaxel]], [[Palbociclib]], [[panobinostat]], [[para-amino salicylic acid]], [[pazopanib]], [[Pegademase]], [[Peginterferon Beta-1a]],[[pemetrexed]], [[penicillamine]], [[pentamidine Isethionate]], [[pentostatin]], [[phenylbutazone]], [[phenytoin]], [[Pergolide]], [[Pertuzumab]], [[pixantrone]], [[Plerixafor]], [[pomalidomide]], [[ponatinib]], [[pralatrexate]], [[pramipexole]], [[procarbazine]], [[promethazine]], [[proton pump inhibitors]], [[pyrimethamine]], [[quinidine]], [[quinine]], [[Rabeprazole]], [[Radium chloride]], [[raltitrexed]], [[ranitidine]], [[regorafenib]], [[reoPro]], [[repaglinide]], [[rifampicin]], [[Ritonavir]], [[rituximab]], [[romidepsin]], [[Romiplostim]], [[ruxolitinib]], [[Siltuximab]], [[sirolimus]], [[Sodium aurothiomalate]], [[sorafenib]], [[stiripentol]], [[Streptozocin]], [[Sulfacetamide]], [[Sulfamethoxazole/Trimethoprim (oral)]], [[sulfasalazine]], [[sulindac]], [[sulfonamides]], [[sunitinib malate]], [[Spironolactone]], [[Tacrolimus]], [[Tamoxifen]], [[temozolomide]], [[temsirolimus]], [[teniposide]], [[thalidomide]], [[thioguanine]], [[thiotepa]], [[Thiothixene]], [[Tiagabine]], [[ticlopidine]], [[tinzaparin]], [[tirofiban]], [[tocilizumab]], [[topotecan]], [[Tolmetin]], [[Tolazamide]], [[Toremifene]], [[tositumomab iodine-131]], [[trabectedin]], [[Trimethadione]], [[trimethoprim-sulfamethoxazole]], [[tolbutamide]], [[valganciclovir]], [[valproic acid]], [[vancomycin]], [[Vinblastine]], [[Vincristine sulfate liposome]] [[vinflunine]], [[vinorelbine]], [[vorinostat]], [[ziv-aflibercept]], [[zonisamide]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Ear Nose Throat''' | |||
| bgcolor="Beige" | [[Alport syndrome]], [[Arias oculootoradial syndrome]], [[Epstein's syndrome]], [[Fechtner syndrome]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Endocrine''' | |||
| bgcolor="Beige" | [[Immunodysregulation polyendocrinopathy and enteropathy, X-linked]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Environmental''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Gastroenterologic''' | |||
| bgcolor="Beige" | [[aminoaciduria|Dibasic aminoaciduria type 2]], [[liver failure]], [[Niemann-Pick disease|Niemann-Pick disease type b]], [[portal hypertension]], [[Shwachman-Diamond syndrome]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Genetic''' | |||
| bgcolor="Beige" | [[Aicardi-Goutieres syndrome]], [[Alport syndrome]], [[Chediak-Higashi disease]], [[factor H|complement factor H deficiency]], [[Elejalde syndrome]], [[Fanconi anaemia]], [[Fechtner syndrome]], [[Griscelli syndrome|Griscelli syndrome type 1]], [[holocarboxylase synthase deficiency]], [[iminodipeptiduria]], [[Jacobsen syndrome]], [[MELAS]], [[neuroectodermal melanolysosomal disease]], [[Niemann-Pick disease|Niemann-Pick disease type b]], [[Omenn syndrome]], [[Paris-Trousseau thrombocytopenia]], [[Shwachman-Diamond syndrome]], [[TAR syndrome]], [[TAR syndrome|Thrombocytopenia absent radius syndrome]], [[Von Willebrand disease|Von Willebrand disease, platelet type]], [[Wiskott-Aldrich syndrome]], [[X-linked hyperimmunoglobulin M syndrome]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Hematologic''' | |||
| bgcolor="Beige" | [[Acquired pure megakaryocytic aplasia]], [[aplastic anemia]], [[Bernard-Soulier syndrome]], [[thrombocytopenia|congenital amegakaryocytic thrombocytopenia (CAMT)]], [[disseminated intravascular coagulation]], [[Epstein's syndrome]], [[familial histiocytic reticulosis]], [[Gasser syndrome]], [[GATA1|GATA1-related cytopenia]], [[Glanzmann's thrombasthenia]], [[grey platelet syndrome]], [[hemolytic uremic syndrome]], [[histiocytosis X]], [[hypersplenism]], [[idiopathic thrombocytopenic purpura]], [[Jacobsen syndrome]], [[Kasabach-Merritt syndrome]], [[May-Hegglin anomaly]], [[Moschcowitz syndrome]], [[myelodysplastic syndrome]], [[myelofibrosis]], [[neonatal alloimmune thrombocytopenia]], [[pancytopenia]], [[Paris-Trousseau thrombocytopenia]], [[paroxysmal nocturnal hemoglobinuria]], [[post-transfusion purpura]], [[pulmonary embolism]], [[TAR syndrome|radial aplasia-thrombocytopenia syndrome]], [[Sebastian platelet syndrome]], [[Shwachman-Diamond syndrome]], [[thrombotic thrombocytopenic purpura]], [[Von Willebrand disease|Von Willebrand disease, platelet type]], [[Werlhof disease]], [[Wiskott-Aldrich syndrome]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Iatrogenic''' | |||
| bgcolor="Beige" | [[coronary artery bypass surgery|Cardiac bypass]], [[chemotherapy]], [[intra-aortic balloon pump|intra-aortic balloon pump placement]], [[blood transfusion|massive blood transfusion]], [[radiation therapy]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Infectious Disease''' | |||
| bgcolor="Beige" | [[Congenital syphilis]], [[cytomegalovirus]], [[Dengue fever]], [[ehrlichiosis]], [[Epstein-Barr virus]], [[hantavirus]], [[hepatitis C]], [[HIV]], [[human granulocytic ehrlichiosis]], [[ehrlichiosis|human monocytotropic ehrlichiosis]], [[infections]], [[infectious mononucleosis]], [[lassa fever]], [[leptospirosis]], [[malaria]], [[measles]], [[mumps]], [[mycoplasma pneumonia]], [[relapsing fever|Oklahoma tick fever]], [[parvovirus]], [[Q fever]], [[rubella]], [[septicaemia]], [[tick-borne encephalitis]], [[toxic shock syndrome|toxic shock syndrome (staphylococcal)]], [[varicella]], [[visceral leishmaniasis]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Musculoskeletal/Orthopedic''' | |||
| bgcolor="Beige" | [[Arias oculootoradial syndrome]], [[cholesterol embolism]], [[TAR syndrome|radial aplasia-thrombocytopenia syndrome]], [[TAR syndrome]], [[TAR syndrome|thrombocytopenia absent radius syndrome]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Neurologic''' | |||
| bgcolor="Beige" | [[Aicardi-Goutieres syndrome]], [[Jacobsen syndrome]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Nutritional/Metabolic''' | |||
| bgcolor="Beige" | [[aminoaciduria|Dibasic aminoaciduria type 2]], [[folate deficiency]], [[Gaucher disease]], [[holocarboxylase synthase deficiency]], [[iminodipeptiduria]], [[iron deficiency]], [[isovaleric acidaemia]], [[methylmalonic aciduria|methylmalonic aciduria type 2]], [[CD36|platelet glycoprotein 4 deficiency]], [[platelet glycoprotein Ib deficiency]], [[prolidase deficiency]], [[propionyl-CoA carboxylase deficiency]], [[sea blue histiocytosis]], [[sitosterolemia]], [[vitamin B12 deficiency]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Obstetric/Gynecologic''' | |||
| bgcolor="Beige" | [[Eclampsia]], [[HELLP syndrome]], [[pre-eclampsia]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Oncologic''' | |||
| bgcolor="Beige" | [[Acute lymphoblastic leukemia]], [[acute myeloid leukemia]], [[acute promyelocytic leukemia]], [[chronic lymphocytic leukaemia]], [[chronic myeloid leukaemia]], [[hairy cell leukaemia]], [[hepatosplenic T-cell lymphoma]], [[histiocytosis X]], [[Kasabach-Merritt syndrome]], [[lymphoma]], [[myeloma]], [[Non-Hodgkins lymphoma]], [[paraneoplastic syndrome]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Ophthalmologic''' | |||
| bgcolor="Beige" | [[Arias oculootoradial syndrome]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Overdose/Toxicity''' | |||
| bgcolor="Beige" | [[Alcohol]], [[arsenic trioxide]], [[ethanol]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Psychiatric''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Pulmonary''' | |||
| bgcolor="Beige" | [[Acute respiratory distress syndrome]], [[Niemann-Pick disease|Niemann-Pick disease type b]], [[pulmonary embolism]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Renal/Electrolyte''' | |||
| bgcolor="Beige" | [[Alport syndrome]], [[cholesterol embolism]], [[aminoaciduria|Dibasic aminoaciduria type 2]], [[Epstein's syndrome]], [[Fechtner syndrome]], [[hemolytic uremic syndrome]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Rheumatology/Immunology/Allergy''' | |||
| bgcolor="Beige" | [[Anticardiolipin syndrome]], [[antiphospholipid syndrome]], [[autoimmune lymphoproliferative syndrome type 1]], [[autoimmune lymphoproliferative syndrome type 2]], [[factor H|complement factor H deficiency]], [[Evans syndrome]], [[immunodysregulation polyendocrinopathy and enteropathy, X-linked]], [[macrophage-activation syndrome]], [[neonatal alloimmune thrombocytopenia]], [[Omenn syndrome]], [[paraneoplastic syndrome]], [[systemic lupus erythematosus]], [[Wiskott-Aldrich syndrome]], [[X-linked hyperimmunoglobulin M syndrome]] | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Sexual''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Trauma''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Urologic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Miscellaneous''' | |||
| bgcolor="Beige" | [[Snakebites]] | |||
|- | |||
|} | |||
===Causes in Alphabetical Order=== | ===Causes in Alphabetical Order=== | ||
{{col-begin|width=80%}} | |||
{{col-break|width=33%}} | |||
*[[5-azacytidine]] | |||
*[[Abciximab]] | |||
*[[Aclarubicin]] | |||
*[[ | *[[Acquired pure megakaryocytic aplasia]] | ||
*[[ | *[[Actinomycin D]] | ||
*[[ | *[[Acute lymphoblastic leukemia]] | ||
*[[ | |||
*[[ | |||
*[[Acute lymphoblastic leukemia]] | |||
*[[Acute myeloid leukemia]] | *[[Acute myeloid leukemia]] | ||
*[[Acute promyelocytic leukemia]] | |||
*[[Acute respiratory distress syndrome]] | |||
*[[Ado-trastuzumab emtansine]] | |||
*[[Aflibercept]] | |||
*[[Aggrastat]] | |||
*[[Aicardi-Goutieres syndrome]] | |||
*[[Albendazole]] | |||
*[[Alcohol]] | |||
*[[Alemtuzumab]] | |||
*[[Alport syndrome]] | |||
*[[Altretamine]] | |||
*[[Amiodarone]] | |||
*[[Amoxicillin]] | |||
*[[Amphotericin B]] | |||
*[[Amrinone]] | |||
*[[Amsacrine]] | |||
*[[Anagrelide]] | |||
*[[Anazolene]] | |||
*[[Anticardiolipin syndrome]] | |||
*[[Antiphospholipid syndrome]] | |||
*[[Anti-thymocyte globulin]] | |||
*[[Aplastic anemia]] | |||
*[[Ardeparin]] | |||
*[[Arias oculootoradial syndrome]] | |||
*[[Arsenic trioxide]] | |||
*[[Autoimmune lymphoproliferative syndrome type 1]] | |||
*[[Autoimmune lymphoproliferative syndrome type 2]] | |||
*[[Azathioprine]] | |||
*[[Aztreonam]] | |||
*[[Bendamustine]] | |||
*[[Benoxaprofen]] | |||
*[[Bernard-Soulier syndrome]] | |||
*[[Bevacizumab]] | |||
*[[Boceprevir]] | |||
*[[Bortezomib]] | |||
*[[Bosutinib]] | |||
*[[Brentuximab vedotin]] | |||
*[[Cabazitaxel]] | |||
*[[Capecitabine]] | |||
*[[Captopril]] | |||
*[[Carboplatin]] | |||
*[[coronary artery bypass surgery|Cardiac bypass]] | |||
*[[Carfilzomib]] | |||
*[[Carmustine]] | |||
*[[Caspofungin]] | |||
*[[Cefadroxil]] | |||
*[[Cefepime]] | |||
*[[Cefotaxime sodium]] | |||
*[[Ceftazidime]] | |||
*[[Chediak-Higashi disease]] | |||
*[[Chemotherapy]] | |||
*[[Chlorambucil]] | |||
*[[Chloramphenicol]] | |||
*[[Chlorpropamide]] | |||
*[[Cholesterol embolism]] | |||
*[[Chronic lymphocytic leukaemia]] | *[[Chronic lymphocytic leukaemia]] | ||
*[[Chronic myeloid leukaemia]] | *[[Chronic myeloid leukaemia]] | ||
*[[Cidofovir]] | |||
*[[Cilazapril]] | |||
*[[Cimetidine]] | |||
*[[Cisplatin]] | |||
*[[Cladribine]] | |||
*[[Clofarabine]] | |||
*[[factor H|Complement factor H deficiency]] | |||
*[[thrombocytopenia|Congenital amegakaryocytic thrombocytopenia (CAMT)]] | |||
*[[Cyclophosphamide]] | |||
*[[Cytomegalovirus]] | |||
*[[Cytarabine]] | |||
*[[Cytosine arabinoside]] | |||
*[[Dacarbazine]] | |||
*[[Dasatinib]] | |||
*[[Daunorubicin]] | |||
*[[Decitabine]] | |||
*[[Dengue fever]] | |||
*[[Desferrioxamine]] | |||
*[[Desmopressin]] | |||
*[[aminoaciduria|Dibasic aminoaciduria type 2]] | |||
*[[Didanosine]] | |||
*[[Disseminated intravascular coagulation]] | |||
*[[Docetaxel]] | |||
*[[Doxorubicin Hydrochloride]] | |||
*[[platelet|Drug-induced thrombocytopenia]] | |||
{{col-break|width=33%}} | |||
*[[Eclampsia]] | |||
*[[Efalizumab]] | |||
*[[Eflornithine]] | |||
*[[Ehrlichiosis]] | |||
*[[Elejalde syndrome]] | |||
*[[Endocarditis]] | |||
*[[Enoxaparin]] | |||
*[[Epirubicin hydrochloride]] | |||
*[[Epstein's syndrome]] | |||
*[[Epstein-Barr virus]] | |||
*[[Eptifibatide]] | |||
*[[Eribulin]] | |||
*[[Ethanol]] | |||
*[[Etoposide]] | |||
*[[Evans syndrome]] | |||
*[[Everolimus]] | |||
*[[Familial histiocytic reticulosis]] | |||
*[[Fanconi anaemia]] | |||
*[[Fechtner syndrome]] | |||
*[[Filgastrim]] | |||
*[[Flucytosine]] | |||
*[[Fludarabine]] | |||
*[[Fluorouracil]] | |||
*[[Folate deficiency]] | |||
*[[Fondaparinux]] | |||
*[[Foscarnet]] | |||
*[[Ganciclovir]] | |||
*[[Gasser syndrome]] | |||
*[[GATA1|GATA1-related cytopenia]] | |||
*[[Gaucher disease]] | |||
*[[Gemcitabine]] | |||
*[[Gemtuzumab ozogamicin]] | |||
*[[Glanzmann's thrombasthenia]] | |||
*[[Glycoprotein IIb/IIIa inhibitors]] | |||
*[[Gold salts]] | |||
*[[Grey platelet syndrome]] | |||
*[[Griscelli syndrome|Griscelli syndrome type 1]] | |||
*[[Guanidinium]] | |||
*[[Haem arginate]] | |||
*[[Hairy cell leukaemia]] | *[[Hairy cell leukaemia]] | ||
*[[Hantavirus]] | *[[Hantavirus]] | ||
*[[HIV- | *[[HELLP syndrome]] | ||
*[[Hemolytic uremic syndrome]] | |||
*[[Heparin]] | |||
*[[Hepatitis C]] | |||
*[[Hepatosplenic T-cell lymphoma]] | |||
*[[Histiocytosis X]] | |||
*[[HIV]] | |||
*[[Holocarboxylase synthase deficiency]] | |||
*[[Human granulocytic ehrlichiosis]] | |||
*[[ehrlichiosis|Human monocytotropic ehrlichiosis]] | |||
*[[Hydroxycarbamide]] | |||
*[[Hydroxyurea (patient information)]] | |||
*[[Hypersplenism]] | |||
*[[Ibritumomab tiuxetan]] | |||
*[[Ibrutinib]] | |||
*[[Ibuprofen lysine]] | |||
*[[Idarubicin]] | |||
*[[Idiopathic thrombocytopenic purpura]] | |||
*[[Ifosfamide]] | |||
*[[Imatinib mesylate]] | |||
*[[Iminodipeptiduria]] | |||
*[[Immunodysregulation polyendocrinopathy and enteropathy, X-linked]] | |||
*[[Indinavir]] | |||
*[[Indomethacin]] | |||
*[[Infections]] | |||
*[[Infectious mononucleosis]] | *[[Infectious mononucleosis]] | ||
*[[Infliximab]] | |||
*[[Integrilin]] | |||
*[[Interferon alpha]] | |||
*[[Interferon gamma]] | |||
*[[Interleukin 10]] | |||
*[[Interleukin 2]] | |||
*[[intra-aortic balloon pump|Intra-aortic balloon pump placement]] | |||
*[[Irinotecan hydrochloride]] | |||
*[[Iron deficiency]] | |||
*[[Isoniazid]] | |||
*[[Isotretinoin]] | |||
*[[Isovaleric acidaemia]] | |||
*[[Ixabepilone]] | |||
*[[Jacobsen syndrome]] | |||
*[[Kasabach-Merritt syndrome]] | |||
*[[Lassa fever]] | *[[Lassa fever]] | ||
*[[Lenalidomide]] | |||
{{col-break|width=33%}} | |||
*[[Leptospirosis]] | |||
*[[Linezolid]] | |||
*[[Liver failure]] | |||
*[[Lomustine]] | |||
*[[Low molecular weight heparin]]s | |||
*[[Lymphoma]] | |||
*[[Macrophage-activation syndrome]] | |||
*[[Malaria]] | |||
*[[Massive blood transfusion]] | |||
*[[May-Hegglin anomaly]] | |||
*[[Measles]] | *[[Measles]] | ||
*[[MELAS]] | |||
*[[Melphalan]] | |||
*[[Mercaptopurine]] | |||
*[[Methotrexate]] | |||
*[[Methyldopa]] | |||
*[[Methyldopate]] | |||
*[[methylmalonic aciduria|Methylmalonic aciduria type 2]] | |||
*[[Methylphenidate]] | |||
*[[Micafungin sodium]] | |||
*[[Milnacipran hydrochloride]] | |||
*[[Mithramycin]] | |||
*[[Mitomycin C]] | |||
*[[Mitoxantrone]] | |||
*[[MMR vaccine]] | |||
*[[Montelukast]] | |||
*[[Moschcowitz syndrome]] | |||
*[[Mumps]] | *[[Mumps]] | ||
*[[Mycoplasma pneumonia]] | |||
*[[ | *[[Myelodysplastic syndrome]] | ||
* | *[[Myelofibrosis]] | ||
*[[Myeloma]] | |||
*[[Nelarabine]] | |||
*[[Neonatal alloimmune thrombocytopenia]] | |||
*[[Neuroectodermal melanolysosomal disease]] | |||
*[[ | *[[Niacin]] | ||
*[[ | *[[Niemann-Pick disease|Niemann-Pick disease type b]] | ||
*[[Nilotinib]] | |||
*[[Nitisinone]] | |||
*[[Non-Hodgkins lymphoma]] | |||
*[[ | *[[Obinutuzumab]] | ||
*[[ | *[[relapsing fever|Oklahoma tick fever]] | ||
*[[ | *[[Omacetaxine mepesuccinate]] | ||
*[[ | |||
*[[ | |||
*[[ | |||
*[[ | |||
*[[ | |||
*[[ | |||
*[[ | |||
*[[ | |||
*[[Omenn syndrome]] | *[[Omenn syndrome]] | ||
*[[Oxaliplatin]] | |||
*[[Oxaprozin]] | |||
*[[Paclitaxel]] | |||
*[[Palbociclib]] | |||
*[[Pancytopenia]] | |||
*[[Panobinostat]] | |||
*[[Para-amino salicylic acid]] | |||
*[[Paraneoplastic syndrome]] | |||
*[[Paris-Trousseau thrombocytopenia]] | |||
*[[Paroxysmal nocturnal hemoglobinuria]] | |||
*[[Parvovirus]] | |||
*[[Pazopanib]] | |||
*[[Peginterferon Beta-1a]] | |||
*[[Pemetrexed]] | |||
*[[Penicillamine]] | |||
*[[Pentamidine]] | |||
*[[Pentostatin]] | |||
*[[Pergolide]] | |||
*[[Phenylbutazone]] | |||
*[[Phenytoin]] | |||
*[[Pixantrone]] | |||
*[[CD36|Platelet glycoprotein 4 deficiency]] | |||
*[[Platelet glycoprotein Ib deficiency]] | *[[Platelet glycoprotein Ib deficiency]] | ||
*[[Propionyl-CoA carboxylase deficiency]] | *[[Plerixafor]] | ||
*[[Pomalidomide]] | |||
*[[Ponatinib]] | |||
*[[Portal hypertension]] | |||
*[[Post-transfusion purpura]] | |||
*[[Pralatrexate]] | |||
*[[Pre-eclampsia]] | |||
*[[Procarbazine]] | |||
*[[Prolidase deficiency]] | |||
*[[Propionyl-CoA carboxylase deficiency]] | |||
*[[Proton pump inhibitors]] | |||
*[[Pulmonary embolism]] | |||
*[[Pyrimethamine]] | |||
*[[Q fever]] | |||
*[[Quinidine]] | |||
*[[Quinine]] | |||
*[[TAR syndrome|Radial aplasia-thrombocytopenia syndrome]] | |||
{{col-break|width=33%}} | |||
*[[Radiation therapy]] | |||
*[[Radium chloride]] | |||
*[[Raltitrexed]] | |||
*[[Ranitidine]] | |||
*[[Regorafenib]] | |||
*[[ReoPro]] | |||
*[[Rifampicin]] | |||
*[[Rituximab]] | |||
*[[Romidepsin]] | |||
*[[Rubella]] | |||
*[[Ruxolitinib]] | |||
*[[Sea blue histiocytosis]] | *[[Sea blue histiocytosis]] | ||
*[[Sebastian platelet syndrome]] | |||
*[[Septicaemia]] | |||
*[[Shwachman-Diamond syndrome]] | *[[Shwachman-Diamond syndrome]] | ||
*[[Siltuximab]] | |||
*[[Sirolimus]] | |||
* | *[[Sitosterolemia]] | ||
* | *[[Snakebites]] | ||
*[[Sorafenib]] | |||
*[[Stiripentol]] | |||
*[[Streptozocin]] | |||
*[[Strontium-89]] | |||
*[[Sulfasalazine]] | |||
*[[Sulfonamides]] | |||
*[[Sunitinib malate]] | |||
*[[Congenital syphilis]] | |||
*[[Systemic lupus erythematosus]] | |||
*[[Tacrolimus]] | |||
*[[Tamoxifen]] | |||
*[[TAR syndrome]] | |||
*[[Temozolomide]] | |||
*[[Temsirolimus]] | |||
*[[Teniposide]] | |||
*[[Thioguanine]] | |||
*[[Thiotepa]] | |||
*[[thrombocytopenia absent radius|Thrombocytopenia absent radius syndrome]] | |||
*[[Thrombotic thrombocytopenic purpura]] | |||
*[[Tiagabine]] | |||
*[[Tick-borne encephalitis]] | |||
*[[Ticlopidine]] | |||
*[[Tinzaparin]] | |||
*[[Tirofiban]] | |||
*[[Topotecan]] | |||
*[[Tositumomab iodine-131]] | |||
*[[toxic shock syndrome|Toxic shock syndrome (staphylococcal)]] | |||
*[[Trabectedin]] | |||
*[[Trimethoprim-sulfamethoxazole]] | |||
*[[Valganciclovir]] | |||
*[[Valproic acid]] | |||
*[[Vancomycin]] | |||
*[[Varicella]] | |||
*[[Vinflunine]] | |||
*[[Vinorelbine]] | |||
*[[Visceral leishmaniasis]] | |||
*[[Vitamin B12 deficiency]] | |||
*[[von Willebrand disease|Von willebrand disease, platelet type]] | |||
*[[Vorinostat]] | |||
*[[Werlhof disease]] | |||
*[[Wiskott-Aldrich syndrome]] | *[[Wiskott-Aldrich syndrome]] | ||
*X-linked hyperimmunoglobulin M syndrome | *[[X-linked hyperimmunoglobulin M syndrome]] | ||
* | *[[Zinc]] | ||
*[[ | *[[Ziv-aflibercept]] | ||
{{col-end}} | |||
=== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Crowdiagnosis]] | |||
[[Category:Hematology]] | |||
{{WH}} | |||
{{WS}} | |||
{{ | |||
{{ | |||
Latest revision as of 21:43, 3 October 2018
Thrombocytopenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombocytopenia causes On the Web |
American Roentgen Ray Society Images of Thrombocytopenia causes |
Risk calculators and risk factors for Thrombocytopenia causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2], Farbod Zahedi Tajrishi, M.D. [2]
Overview
There are two broad mechanisms for the causes of thrombocytopenia: Reduced platelet production and increased platelet destruction. Thrombocytopenia is seen in a variety of infectious and genetic disorders as well as a side effect of a large list of medications.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Abruptio placentae[1]
- Bone marrow suppression (chemotherapy, irradiation)
- Cardica bypass[1]
- Chronic alcohol use
- Chronic liver disease[2]
- Common variable immunodeficiency[1]
- Congenital thrombocytopenia
- Connective tissue disorders (eg SLE, RA, antiphospholipid syndrome)[1]
- Disseminated intravascular coagulation[2]
- GP IIb/IIIa inhibitor[1]
- Hemolytic uremic syndrome
- Heparin-induced thrombocytopenia
- Immune thrombocytopenic purpura[3]
- Infections[2]
- Macrophage-activation syndrome[1]
- Medications[2]
- Preeclampsia
- Pregnancy[4]
- Pseudothrombocytopenia
- Thrombotic thrombocytopenic purpura[5]
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 Stasi R (2012). "How to approach thrombocytopenia". Hematology Am Soc Hematol Educ Program. 2012: 191–7. doi:10.1182/asheducation-2012.1.191. PMID 23233580.
- ↑ 2.0 2.1 2.2 2.3 Greenberg EM, Kaled ES (2013). "Thrombocytopenia". Crit Care Nurs Clin North Am. 25 (4): 427–34, v. doi:10.1016/j.ccell.2013.08.003. PMID 24267279.
- ↑ Farid J, Gul N, Qureshi WU, Idris M (2012). "Clinical presentations in immune thrombocytopenic purpura". J Ayub Med Coll Abbottabad. 24 (2): 39–40. PMID 24397048.
- ↑ Nisha S, Amita D, Uma S, Tripathi AK, Pushplata S (2012). "Prevalence and characterization of thrombocytopenia in pregnancy in Indian women". Indian J Hematol Blood Transfus. 28 (2): 77–81. doi:10.1007/s12288-011-0107-x. PMC 3332269. PMID 23730013.
- ↑ Abdel Karim N, Haider S, Siegrist C, Ahmad N, Zarzour A, Ying J; et al. (2013). "Approach to management of thrombotic thrombocytopenic purpura at university of cincinnati". Adv Hematol. 2013: 195746. doi:10.1155/2013/195746. PMC 3876823. PMID 24396345.